NZ born and raised researcher at @MDAndersonNews focused on the molecular basis for B-cell #lymphoma. Opinions are my own.
Joined March 2015
- Tweets 1,026
- Following 606
- Followers 1,228
- Likes 1,548
35 Photos and videos
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
brnw.ch/21x1Sht
#AACRlymphoma26 @GreenLymphoLab
4
5
1,382
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
brnw.ch/21x1o6g
#AACRlymphoma26
2
2
1
1,266
Deadline Extended:Submit an abstract by April 6 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML).
brnw.ch/21x1bbJ
#AACRlymphoma26 @GreenLymphoLab
2
3
1,211
#AACRlymphoma26 chair Michael R. Green invites you to submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with ICML. Learn more:
brnw.ch/21x15pZ
@GreenLymphoLab
4
7
1,718
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
brnw.ch/21x10Xh
#AACRlymphoma26 @GreenLymphoLab
4
1
1,258
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
brnw.ch/21x0OLd
#AACRlymphoma26 @GreenLymphoLab
4
6
1,177
Abstract submissions are open for the AACR/ICML Advances in Malignant Lymphoma meeting!!
June 24-27 in Philadelphia. Please retweet.
aacr.org/meeting/advances-in…
6
8
814
Need PDX models for Lymphoma research? Check out our newest preprint: biorxiv.org/content/10.64898…
We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm
4
15
1,334
10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.
1
4
195
I would prefer as an author that reviewers have the time they need to review the paper carefully. 4 days does not mean a lot in the life of a study that has taken multiple years.
1
163
21 Oct 2025
Spatial profiling of diffuse large B-cell lymphoma.
I'm happy to share our latest paper, published today in @NatureGenet - a collaborative effort with @IamLinghua.
nature.com/articles/s41588-0…
3
5
24
1,461
21 Oct 2025
Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.
1
5
193
21 Oct 2025
This provides an initial framework for understanding spatially resolved cellular ecosystems in DLBCL, highlighting how microenvironment architecture can shape disease biology. But we are just scratching the surface.
1
6
133
Michael Green, PhD retweeted
20 Oct 2025
Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (x.com/PhRMAfoundation/status…).
👉👉biorxiv.org/content/10.1101/…
2 Oct 2025
#PhF25 awardee Yu-Hsiang Chen, a postdoc @MDAndersonNews, is using single-cell technology to study #cancer cells that remain after stem cell transplant. Understanding these cells could help develop better treatments. @pbachi
Watch the full interview: phrmafoundation.org/news-eve…
2
15
28
8,745
5 Aug 2025
Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 months to get an accession number and even longer for data to be released is a curse to research progress. There must be another way.
1
1
11
878
6 Jul 2025
Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions focused on the cutting edge of basic and translational research in Lymphoma. @AACR @icmlugano #lmsm
3
26
1,458
18 Jun 2025
Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by @dgermain21 at #18icml @icmlugano, now available online in Cancer Cell. #lmsm @washumedicine @MDAndersonNews.
cell.com/cancer-cell/fulltex…
4
29
88
8,650
18 Jun 2025
Thrilled to see @dgermain21 present our work as a plenary at #18ICML, with excellent discussion from Steve Ansell. The paper will be online tonight, with a summary to follow.
7
5
49
3,079
19 Mar 2025
For those of you who have had a hard time with papers, this was a doozie. Several editorial desk rejections, all for different reasons, and then an extensive 41-page rebuttal required for revision at Blood. All told, ~2 years from first submission to acceptance. Just keep at it!!
18 Mar 2025
Now online, a monster effort from Haopeng Yang & Wenchao Zhang in collaboration with Fernando Rodrigues-Lima @univ_paris_cite: Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement. #lmsm ashpublications.org/blood/ar…
14
974